The latest price target for TFF Pharmaceuticals (NASDAQ:TFFP) was reported by Roth MKM on March 28, 2024. The analyst firm set a price target for $44.00 expecting TFFP to rise to within 12 months (a possible 11772.64% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for TFF Pharmaceuticals (NASDAQ:TFFP) was provided by Roth MKM, and TFF Pharmaceuticals maintained their buy rating.

There is no last upgrade for TFF Pharmaceuticals

There is no last downgrade for TFF Pharmaceuticals.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TFF Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TFF Pharmaceuticals was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.

While ratings are subjective and will change, the latest TFF Pharmaceuticals (TFFP) rating was a maintained with a price target of $56.00 to $44.00. The current price TFF Pharmaceuticals (TFFP) is trading at is $0.37, which is out of the analyst’s predicted range.